Edap Tms SA (NASDAQ:EDAP) received a $7.00 price target from investment analysts at HC Wainwright in a report released on Monday. The firm currently has a “buy” rating on the medical equipment provider’s stock. HC Wainwright’s price target would suggest a potential upside of 149.11% from the stock’s previous close.

Several other equities analysts have also recently weighed in on the stock. Zacks Investment Research cut shares of Edap Tms SA from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 11th. ValuEngine raised shares of Edap Tms SA from a “sell” rating to a “hold” rating in a research report on Friday.

Edap Tms SA (NASDAQ:EDAP) traded down 6.33% during mid-day trading on Monday, reaching $2.81. The company had a trading volume of 95,701 shares. The stock has a 50 day moving average price of $2.58 and a 200 day moving average price of $2.93. Edap Tms SA has a one year low of $2.25 and a one year high of $3.62. The company has a market capitalization of $81.48 million, a P/E ratio of 19.79 and a beta of 1.02.

Edap Tms SA (NASDAQ:EDAP) last announced its quarterly earnings results on Wednesday, May 17th. The medical equipment provider reported $0.13 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.03) by $0.16. Edap Tms SA had a net margin of 27.77% and a return on equity of 30.13%. The business had revenue of $9.29 million for the quarter, compared to analysts’ expectations of $9.35 million. On average, equities analysts expect that Edap Tms SA will post ($0.01) earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This article was posted by American Banking News and is the property of of American Banking News. If you are reading this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright law. The original version of this article can be viewed at https://www.americanbankingnews.com/2017/05/23/edap-tms-sa-edap-given-a-7-00-price-target-at-hc-wainwright.html.

A hedge fund recently raised its stake in Edap Tms SA stock. Morgan Stanley boosted its stake in Edap Tms SA (NASDAQ:EDAP) by 116.7% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 66,300 shares of the medical equipment provider’s stock after buying an additional 35,700 shares during the period. Morgan Stanley owned 0.23% of Edap Tms SA worth $184,000 at the end of the most recent quarter. Institutional investors own 9.47% of the company’s stock.

About Edap Tms SA

EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.

12 Month Chart for NASDAQ:EDAP

Receive News & Ratings for Edap Tms SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms SA and related companies with MarketBeat.com's FREE daily email newsletter.